Lupin Receives China Approval for Oseltamivir Phosphate Oral Suspension

Marks Lupin's Debut in the Chinese Market MUMBAI, India and BEIJING, May 22, 2026 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced that China's National Medical Products Administration has approved...

Read More